Flo Health was established in 2014; since then, Flo Health has increased its usage to over 300 million people around the globe, emphasizing the idea of knowing your body and owning your health. The Flo app can track ovulation and period, provide a fertility calendar, and provide pregnancy assistance. Women prefer to use flow due to their experience in the field and the privacy regulations.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/30/2024 | Series C | $200MM | $xx.xx | $1.2B | General Atlantic | |
Price per Share
$xx.xx
Shares Outstanding
3,354,581
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Atlantic
|
||||||
09/21/2021 | Series B | $31.71MM | $xx.xx | $804.36MM | Target Global, Vnv Global | |
Price per Share
$xx.xx
Shares Outstanding
1,371,509
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Target Global, Vnv Global
|
||||||
09/21/2021 | Series B-1 | $18MM | $xx.xx | $804.36MM | Target Global, Vnv Global | |
Price per Share
$xx.xx
Shares Outstanding
348,860
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Target Global, Vnv Global
|
||||||
12/19/2018 | Series A-2 | $4.72MM | $xx.xx | $225.38MM | Flint Capital, Haxus Venture Fund, Mangrove Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,095,130
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flint Capital, Haxus Venture Fund, Mangrove Capital Partners
|
||||||
12/19/2018 | Series A-3 | $7.5MM | $xx.xx | $225.38MM | Flint Capital, Haxus Venture Fund, Mangrove Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
456,360
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flint Capital, Haxus Venture Fund, Mangrove Capital Partners
|
||||||
08/02/2017 | Series A-1 | $581,493.15 | $xx.xx | $94.32MM | Flint Capital | |
Price per Share
$xx.xx
Shares Outstanding
51,380
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flint Capital
|
||||||
08/02/2017 | Series A | $7.71MM | $xx.xx | $94.32MM | Flint Capital | |
Price per Share
$xx.xx
Shares Outstanding
511,220
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flint Capital
|
||||||
12/15/2016 | Series Seed | $263,250.00 | $xx.xx | $1.32MM | Flint Capital | |
Price per Share
$xx.xx
Shares Outstanding
1,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flint Capital
|